Tardive Dyskinesia with Antipsychotic Medication in Children and Adolescents: A Systematic Literature Review

Frank M. C. Besag (), Michael J. Vasey, Iffah Salim and Chris Hollis
Additional contact information
Frank M. C. Besag: East London NHS Foundation Trust
Michael J. Vasey: East London NHS Foundation Trust
Iffah Salim: East London NHS Foundation Trust
Chris Hollis: NIHR MindTech HealthTech Research Centre, University of Nottingham

Drug Safety, 2024, vol. 47, issue 11, No 3, 1095-1126

Abstract: Abstract Background Tardive dyskinesia (TD) is a persisting, and potentially irreversible, movement disorder associated with treatment with dopamine receptor antagonists. Few data are available on the risk of TD in children and adolescents treated with antipsychotic medication. Objective To review the literature on incidence, risk factors, and treatment options for antipsychotic-associated TD in children and adolescents (aged

Date: 2024
References: View complete reference list from CitEc
Citations:

Downloads: (external link)
http://link.springer.com/10.1007/s40264-024-01446-0 Abstract (text/html)
Access to the full text of the articles in this series is restricted.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:spr:drugsa:v:47:y:2024:i:11:d:10.1007_s40264-024-01446-0

Ordering information: This journal article can be ordered from
http://www.springer.com/adis/journal/40264

DOI: 10.1007/s40264-024-01446-0

Access Statistics for this article

Drug Safety is currently edited by Nitin Joshi

More articles in Drug Safety from Springer
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().